CTNM Competitors & Alternatives
Compare Contineum Therapeutics, Inc. Class A Common Stock with similar stocks in the same industry
Biotechnology
CTNM
Main Stock$14.82
Tradestie Score
49
Market Cap
$308.74M
Analyst Upside
+58.1%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.29
|
$552.46M | - | 48 | Compare |
|
VSTM
Verastem, Inc.
|
$7.32
|
$541.60M | - | 46 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.91
|
$540.97M | - | 48 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.01
|
$529.35M | 13.0 | 49 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$110.26
|
$522.78M | - | 55 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.00
|
$512.39M | - | 48 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.24
|
$505.12M | 2.8 | 47 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.53
|
$493.52M | - | 47 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$109.27
|
$492.21M | - | 40 | Compare |
More CTNM Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry